360 related articles for article (PubMed ID: 18281169)
1. Solid lipid nanoparticles for pulmonary delivery of insulin.
Liu J; Gong T; Fu H; Wang C; Wang X; Chen Q; Zhang Q; He Q; Zhang Z
Int J Pharm; 2008 May; 356(1-2):333-44. PubMed ID: 18281169
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary delivery of insulin by liposomal carriers.
Huang YY; Wang CH
J Control Release; 2006 Jun; 113(1):9-14. PubMed ID: 16730838
[TBL] [Abstract][Full Text] [Related]
4. Lectin-modified solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang N; Ping Q; Huang G; Xu W; Cheng Y; Han X
Int J Pharm; 2006 Dec; 327(1-2):153-9. PubMed ID: 16935443
[TBL] [Abstract][Full Text] [Related]
5. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
6. Novel solid lipid nanoparticles as carriers for oral administration of insulin.
Zhang Z; Lv H; Zhou J
Pharmazie; 2009 Sep; 64(9):574-8. PubMed ID: 19827297
[TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of solid lipid nanoparticles loaded with epirubicin for pulmonary delivery.
Hu L; Jia Y; WenDing
Pharmazie; 2010 Aug; 65(8):585-7. PubMed ID: 20824958
[TBL] [Abstract][Full Text] [Related]
8. The preparation and application of pulmonary surfactant nanoparticles as absorption enhancers in insulin dry powder delivery.
Zhang Y; Zhu J; Tang Y; Chen X; Yang Y
Drug Dev Ind Pharm; 2009 Sep; 35(9):1059-65. PubMed ID: 19640250
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary delivery of insulin lipid suspension].
Jiang ZQ; Lu J
Yao Xue Xue Bao; 2002 May; 37(5):378-82. PubMed ID: 12579846
[TBL] [Abstract][Full Text] [Related]
10. The stability of insulin-loaded polybutylcyanoacrylate nanoparticles in an oily medium and the hypoglycemic effect in diabetic rats.
Hou ZQ; Zhang ZX; Xu ZH; Zhang H; Tong ZF; Leng YS
Yao Xue Xue Bao; 2005 Jan; 40(1):57-64. PubMed ID: 15881329
[TBL] [Abstract][Full Text] [Related]
11. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: formulation, characterization and in vivo evaluation.
Sun S; Liang N; Piao H; Yamamoto H; Kawashima Y; Cui F
J Microencapsul; 2010; 27(6):471-8. PubMed ID: 20113168
[TBL] [Abstract][Full Text] [Related]
12. Biopharmaceutical characterisation of insulin and recombinant human growth hormone loaded lipid submicron particles produced by supercritical gas micro-atomisation.
Salmaso S; Bersani S; Elvassore N; Bertucco A; Caliceti P
Int J Pharm; 2009 Sep; 379(1):51-8. PubMed ID: 19545616
[TBL] [Abstract][Full Text] [Related]
13. Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy.
Zhao YZ; Li X; Lu CT; Xu YY; Lv HF; Dai DD; Zhang L; Sun CZ; Yang W; Li XK; Zhao YP; Fu HX; Cai L; Lin M; Chen LJ; Zhang M
Acta Diabetol; 2012 Aug; 49(4):315-25. PubMed ID: 22124766
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Hassanzadeh K; Mahdavi H; Koohsoltani M; Nokhodchi A
Biopharm Drug Dispos; 2010 Mar; 31(2-3):189-201. PubMed ID: 20238376
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles as insulin inhalation carriers for enhanced pulmonary delivery.
Bi R; Shao W; Wang Q; Zhang N
J Biomed Nanotechnol; 2009 Feb; 5(1):84-92. PubMed ID: 20055110
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable nanoparticles loaded with insulin-phospholipid complex for oral delivery: preparation, in vitro characterization and in vivo evaluation.
Cui F; Shi K; Zhang L; Tao A; Kawashima Y
J Control Release; 2006 Aug; 114(2):242-50. PubMed ID: 16859800
[TBL] [Abstract][Full Text] [Related]
17. Formulation and characterization of an oily-based system for oral delivery of insulin.
Elsayed A; Remawi MA; Qinna N; Farouk A; Badwan A
Eur J Pharm Biopharm; 2009 Oct; 73(2):269-79. PubMed ID: 19508890
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
[TBL] [Abstract][Full Text] [Related]
19. [In vitro release kinetics and hypoglycemic effect on diabetic rats after oral administration of insulin loaded nanoparticles].
Zhang Q; Ding J; Yie G; Wei S
Yao Xue Xue Bao; 1998; 33(2):152-6. PubMed ID: 11938952
[TBL] [Abstract][Full Text] [Related]
20. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
